Health Desk- 24 Sep 2020: U.S. President Donald Trump said on Wednesday he may or may not approve any new, more stringent FDA standards for an emergency authorization of a COVID-19 vaccine, saying such a proposal would appear political.
Trump may block stricter FDA guidelines for vaccine
“We’re looking at that and that has to be approved by the White House. We may or may not approve it,” Trump told a White House news conference, when asked about the Post report.
Trump added he had “tremendous trust” in those companies.
Few vaccine developers were expected to have definitive trial results before the presidential election. Pfizer Inc PFE.N had been the exception, although its timetable could slip with new guidance.
At the same hearing, U.S. Centers for Disease Control and Prevention head Robert Redfield said he expects there to be about 700 million doses of vaccines available by late March or April, enough for 350 million people.
“I think that’s going to take us April, May, June, you know, possibly July, to get the entire American public completely vaccinated,” Redfield told the U.S. Senate Health, Education, Labor and Pensions Committee.